Abstract
The induction of neoangiogenesis is a critical step already present at the early stages of tumor development and dissemination. The progressive identification of molecules playing a relevant role in neoangiogenesis has fostered the development of a wide variety of new selective agents. Antiangiogenic drugs should be integrated with conventional therapies; however, the design of the best sequence and timing for such combined treatments are still under investigation. In this review will be discussed the signal transduction mechanisms of angiogenic molecules, the development of specific inhibitors and their translation into clinical studies and, finally, the new perspectives in antiangiogenic therapy.
Keywords: Angiogenesis, neoangiogenesis, Antiangiogenic, Cancer Therapy
Current Pharmaceutical Design
Title: Angiogenesis: A Target for Cancer Therapy
Volume: 10 Issue: 1
Author(s): Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
Affiliation:
Keywords: Angiogenesis, neoangiogenesis, Antiangiogenic, Cancer Therapy
Abstract: The induction of neoangiogenesis is a critical step already present at the early stages of tumor development and dissemination. The progressive identification of molecules playing a relevant role in neoangiogenesis has fostered the development of a wide variety of new selective agents. Antiangiogenic drugs should be integrated with conventional therapies; however, the design of the best sequence and timing for such combined treatments are still under investigation. In this review will be discussed the signal transduction mechanisms of angiogenic molecules, the development of specific inhibitors and their translation into clinical studies and, finally, the new perspectives in antiangiogenic therapy.
Export Options
About this article
Cite this article as:
Tortora Giampaolo, Melisi Davide and Ciardiello Fortunato, Angiogenesis: A Target for Cancer Therapy, Current Pharmaceutical Design 2004; 10(1) . https://dx.doi.org/10.2174/1381612043453595
DOI https://dx.doi.org/10.2174/1381612043453595 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Prostaglandin J2 Family and the Cardiovascular System
Current Vascular Pharmacology HPV Viral Activity by mRNA-HPV Molecular Analysis to Screen the Transforming Infections in Precancer Cervical Lesions
Current Pharmaceutical Biotechnology Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era
Anti-Cancer Agents in Medicinal Chemistry Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets A Recent Update on the Role of Ghrelin in Glucose Homeostasis
Current Diabetes Reviews Pharmacological Manipulation of Neural Progenitor Pathways In Situ: Possibilities for Neural Restoration in the Injured Adult Brain
Current Medicinal Chemistry - Central Nervous System Agents The Association between Tumor-associated Macrophages and Glioblastoma: A Potential Target for Therapy
Current Pharmaceutical Design Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer
Clinical Cancer Drugs Fluorescent GPCR Ligands as New Tools in Pharmacology
Current Medicinal Chemistry Increased Expression of Matrix Metalloproteinases Mediates Thromboxane A2-Induced Invasion in Lung Cancer Cells
Current Cancer Drug Targets Tobacco, Inflammation, and Respiratory Tract Cancer
Current Pharmaceutical Design Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response
Current Cancer Drug Targets Marine Food Protection in Testicular Damages Caused by Diabetes Mellitus
Current Diabetes Reviews Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Current Pharmaceutical Design Nanotechnology-Based Drug Delivery Systems for Treatment of Hyperproliferative Skin Diseases - A Review
Current Nanoscience microRNA-133: Expression, Function and Therapeutic Potential in Muscle Diseases and Cancer
Current Drug Targets K-Ras, Intestinal Homeostasis and Colon Cancer
Current Clinical Pharmacology Vagotomy and Gastric Tumorigenesis
Current Neuropharmacology Mechanisms of Herb-Induced Nephrotoxicity
Current Medicinal Chemistry FOXO1: A Potential Target for Human Diseases
Current Drug Targets